Gut Microbiome and Diabetes

The gut microbiome plays a crucial role in glucose metabolism and insulin sensitivity, linking it to the development and management of diabetes. Imbalances in gut bacteria—known as dysbiosis—can trigger inflammation, alter hormone regulation, and impair glucose tolerance. Research shows that specific bacterial strains may either increase or reduce diabetes risk. Diet, probiotics, and prebiotics are being explored to modulate the microbiome and improve metabolic health. Understanding microbiome-host interactions offers promising strategies for early intervention, prevention, and personalized treatment of both type 1 and type 2 diabetes. Microbiome-focused therapies may revolutionize future diabetes management approaches.

    Related Conference of Gut Microbiome and Diabetes

    March 26-27, 2026

    7th Global summit on Diabetes and Endocrinology

    Amsterdam, Netherlands
    May 14-15, 2026

    7th World Summit on Diabetes

    Rome, Italy
    May 18-19, 2026

    57th Annual Congress on Endocrinology and Diabetes Research

    Aix-en-Provence, France
    June 22-23, 2026

    16th World Congress on Endocrinology and Diabetes

    Paris, France
    August 17-18, 2026

    4th World congress and Expo on Diabetes

    Toronto, Canada
    September 29-30, 2026

    22nd World Congress on Endocrinology & Diabetes

    Paris, France

    Gut Microbiome and Diabetes Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in